Berger Montague Investigates Hims & Hers Following Significant Stock Drop and Partnership Termination with Novo Nordisk
Berger Montague, a prominent securities litigation firm, has launched an investigation into Hims & Hers Health, Inc. (NYSE: HIMS) after the company's stock plummeted by more than 26% in a single day. This dramatic fall occurred on June ๐ Full story